Evaluation of Efficacy of Dellegra in Exposure Unit
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To collect and analyze clinical data of Allergic Rhinitis patients' Total Nasal Symptom Score
(TNSS) change after Dellegra internal use under high density pure Japanese cedar pollen
exposure.
Secondary Objective:
To collect and analyze clinical data of Allergic Rhinitis patients' change in Total Symptom
Score (TSS) and amount of nasal discharge, safety, and overall patients' impression about
efficacy of Dellegra after Dellegra internal use under high density pure Japanese cedar
pollen exposure.